Browse Studies — Arctuva

Phase 2

Zavegepant Intranasal Spray for the Acute Treatment of Episodic Cluster Headache: A Prospective, Open-Label, Single-Arm, Interventional Pilot Study

The purpose of this study is to assess headache response rate for minimal pain at 30 minutes following zavegepant administration and to assess additional effec…

Cluster Headache

Estimated

~$10 – $6,250

The University of Texas Health Science Center, HoustonNCT07714369

An Observational Study Assessing the Experience of Patients Undergoing Active Cluster Headache Clinical Trials

Historically, participation in clinical studies is highly skewed towards particular demographic groups of people. This research will invite several participan…

Cluster Headache

Estimated

~$10 – $1,050

Power Life Sciences Inc.NCT05978258

The Will Erwin Headache Research Center Study of Cluster Headache and Trigeminal Neuralgia

The Will Erwin Headache Research Center Study of Cluster Headache and Trigeminal Neuralgia is a prospective, multicenter, observational research network for su…

Cluster HeadacheCluster Headaches and Other Trigeminal Autonomic CephalgiasParoxysmal Hemicrania+3 more

Estimated

~$10 – $750

The University of Texas Health Science Center, HoustonNCT02910323

Phase 2

Prospective, Randomized, Double-blinded, Placebo-controlled, Cross-over Trial of Endoscopically Guided Injection of Exparel (Bupivacaine) Towards the Ipsilateral Pterygopalatine Fossa for the Treatment of Craniofacial Pain

Exparel has a proven efficacy in providing pain relief for up to 72 hours with a single-dose administration at surgical sites. The study aims to evaluate the e…

Craniofacial PainMigraineCluster Headache+3 more

Estimated

~$10 – $6,250

Stanford UniversityNCT04930887